期刊文献+

2014年云南省个旧市恶性肿瘤发病与死亡分析 被引量:4

Analysis of Cancer Incidence and Mortality in Gejiu City of Yunnan Province,2014
原文传递
导出
摘要 [目的]分析云南省个旧市2014年恶性肿瘤的发病和死亡情况,为个旧市癌症防治工作提供科学依据。[方法]评估个旧市2014年恶性肿瘤登记数据质量,计算恶性肿瘤发病(死亡)率、年龄别发病(死亡)率、标化发病(死亡)率、截缩发病(死亡)率及累积发病(死亡)率等指标。[结果]个旧市2014年登记数据的病理学诊断比例(MV%)为63.49%,只有死亡医学证明书比例(DCO%)为1.47%,死亡发病比(M/I)为0.60。2014年个旧市恶性肿瘤粗发病率为225.30/10万,中标率为147.20/10万,世标率为141.43/10万,截缩率为259.03/10万,累积发病率(0-74岁)为16.22%。2014年个旧市恶性肿瘤粗死亡率为134.62/10万,中标率为80.74/10万,世标率为78.58/10万,截缩率为112.82/10万,累积死亡率(0-74岁)为8.88%。发病前10位的恶性肿瘤依次为肺癌、结直肠癌、肝癌、女性乳腺癌、脑肿瘤、膀胱癌、胆囊癌、胃癌、宫颈癌和淋巴瘤,占全部恶性肿瘤发病的72.90%。死亡前10位的恶性肿瘤依次为肺癌、结直肠癌、肝癌、胆囊癌、胃癌、脑肿瘤、淋巴瘤、白血病、卵巢癌和胰腺癌,占全部恶性肿瘤死亡的74.00%。[结论 ]个旧市恶性肿瘤发病率和死亡率低于全国平均水平,肺癌、消化系统恶性肿瘤和女性乳腺癌是威胁个旧市居民的主要恶性肿瘤,应进一步加强肿瘤的防治工作和流行病学调查。 [Purpose] To analyze the incidence and mortality of cancer in Gejiu City in 2014.[Methods] The data quality of Gejiu City malignant tumor registration in 2014 was evaluated. The crude incidence/mortality rates,age-specified incidence/mortality rates,age-standardized incidence/mortality rates,the truncated age-standardized incidence/mortality rates,and cumulative incidence/mortality rates were calculated. [Results] The morphology verified cases(MV%) accounted for63.49% and 1.47% of incident cases were identified through death certifications only(DCO%) with a mortality to incidence ratio(M/I)of 0.60.The crude incidence rate of malignant tumor in Gejiu city in 2014 was 225.30/10^5,the age-standardized incidence rate by Chinese population is 147.20/10^5 and by world population was 141.43/10^5. The truncated age-standardized incidence rate by world population was 259.03/10^5,and the accumulative incidence rate was 16.22%. The mortality rate of malignant tumor in Gejiu city in 2014 was 134.62/10^5,the age-standardized mortality rate by Chinese population was 80.74/10^5 and by world population was 78.58/10^5. The truncated age-standardized mortality rate by world population was 112.82/10^5,and the accumulative mortality rate was 8.88%.The top ten common cancer types were lung cancer,colorectal cancer,liver cancer,female breast cancer,brain tumor,bladder cancer,gallbladder cancer,gastric cancer,cervical cancer and lymphoma,accounting for 72.90% of all cancer cases.Lung cancer,colorectal cancer,liver cancer,gallbladder cancer,gastric cancer,brain tumor,lymphoma,leukemia,ovary cancer and pancreatic cancer were the most common cancer deaths,accounted for 74.00% of all cancer deaths.[Conclusion] The incidence rate and mortality rate of malignant tumor in Gejiu is lower than the national average level. Lung cancer,malignant tumor in the digestive system and female breast cancer are the major cancer burden in residents in Gejiu. Prevention and control and epidemiological investigation of these cancers mentioned above should be strengthened.
作者 王建宁 秦明芳 文卫华 王卫民 周清 潘龙海 陈杨 成会荣 WANG Jian-ningl;QIN Ming-fang;WEN Wei-hua;WANG Wei-min;ZHOU Qing;PAN Long-hai;CHEN Yang;CHENG Hui-rong(The Office of Gejiu Municipal Cancer Prevention and Control Leading Group,Gejiu 661000,China;Yunnan Provincial Center for Disease Prevention and Control,Kunming 650022,China;Gejiu Municipal Health and Family Planning Bureau,Gejiu 661000,China)
出处 《中国肿瘤》 CAS CSCD 北大核心 2018年第10期757-762,共6页 China Cancer
基金 国家自然科学基金资助项目(81160343 30860238)
关键词 肿瘤登记 恶性肿瘤 发病率 死亡率 云南 cancer registration malignant tumor incidence mortality Yunnan
  • 相关文献

参考文献8

二级参考文献45

  • 1段纪俊,陈万青,张思维.中国恶性肿瘤死亡率的国际比较[J].中国社会医学杂志,2009,26(6):377-378. 被引量:46
  • 2Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 3陈明立,谭远发.我国东中西部三大区域人口竞争力实证比较研究[J].经济学家,2007(2):53-63. 被引量:6
  • 4姚树祥,晋萍,范亚光,吴锡南,黄玉辉,杨兰,常润生,姚明鉴,乔友林.云南锡矿工人肺癌高发的流行病学调查(1954~2002年)[J].环境与职业医学,2007,24(5):465-468. 被引量:23
  • 5Yen-Ching Chen,Huey-Jen Jenny Su,Yu-Liang Leon Guo,Yu-Mei Hsueh,Thomas J. Smith,Louise M. Ryan,Meei-Shyuan Lee,David C. Christiani.Arsenic methylation and bladder cancer risk in Taiwan[J].Cancer Causes and Control.2003(4)
  • 6Freddie Bray,D. Max Parkin.??Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness(J)European Journal of Cancer . 2008 (5)
  • 7Felay J,Burkhard C,Whelan S, et al.Check and Conversion Programs for Cancer Registries. IARC Technical Report No.42 . 2005
  • 8Beverly J. Wolpert,Sania Amr,Sameera Ezzat,Doa’a Saleh,Iman Gouda,Iman Loay,Tamer Hifnawy,Nabiel N. Mikhail,Mohamed Abdel-Hamid,Min Zhan,Yun-Ling Zheng,Katherine Squibb,Mohamed A. Abdel-Aziz,Mohamed Zaghloul,Hussein Khaled,Christopher A. Loffredo.??Estrogen exposure and bladder cancer risk in Egyptian women(J)Maturitas . 2010 (4)
  • 9Parkin DM,Chen VW,Ferlay J, et al.Comparability and quality control in cancer registration. IARC Technical Report No. 19 . 1994
  • 10Dawit Melak,Catterina Ferreccio,David Kalman,Roxana Parra,Johanna Acevedo,Liliana Pérez,Sandra Cortés,Allan H. Smith,Yan Yuan,Jane Liaw,Craig Steinmaus.??Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile(J)Toxicology and Applied Pharmacology . 2014 (2)

共引文献1259

同被引文献47

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部